# FDA recall D-0141-2024

> **Wells Pharma of Houston LLC** · Class II · drug recall initiated 2023-11-22.

## Product

ceFAZolin sodium in Sterile Water for injection, Injectable Solution, 1g/10mL (0.1 g per mL), Syringe, Rx only, Wells Pharma, NDC 73702-131-10

## Reason for recall

Lack of assurance of sterility.

## Distribution

Philadelphia, Pennsylvania.

## Key facts

- **Recall number:** D-0141-2024
- **Recalling firm:** Wells Pharma of Houston LLC
- **Classification:** Class II
- **Product type:** drug
- **Status:** Completed
- **Initiation date:** 2023-11-22
- **Report date:** 2023-12-13

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Houston, TX, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0141-2024

## Citation

> AI Analytics. FDA recall D-0141-2024. Retrieved 2026-06-05 from https://api.ai-analytics.org/recall/D-0141-2024. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*